Results 61 to 70 of about 2,982 (119)

Anti-thymocyte globulin (ATG)- or alemtuzumab-based graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic hematopoietic cell transplantation (HCT) for patients 40 years and older with acute lymphoblastic leukemia in first complete remission: a study from the EBMT Acute Leukemia Working Party. [PDF]

Bone Marrow Transplant
Bug G, Labopin M, Byrne JL, Mielke S, Orchard K, Paneesha S, Potter V, Blaise D, Besley C, Snowden JA, Yakoub-Agha I, Clark A, Crawley C, Spyridonidis A, Sanz J, Brissot E, Giebel S, Ciceri F, Mohty M.   +18 more
europepmc   +1 more source

Letter to the editor about: "Eculizumab First" in the Management of Posttransplant Thrombotic Microangiopathy. [PDF]

Kidney Int Rep
Ville S, Drapeau L, Paraire J, Maanaoui M, Frimat M.   +4 more
europepmc   +1 more source

Elevated Matrix Metalloproteinase Type 9 (MMP-9) Transcripts After Thymoglobulin Induction in Incident Kidney Transplant Recipients. [PDF]

Int J Mol Sci
Petersen TBB, Nagarajah S, Tepel M.
europepmc   +1 more source

Immunotherapy as rescue for cardiomyopathy in Omenn syndrome. [PDF]

J Hum Immun
Boutinaud S, Barlogis V, Berthomieu L, Sierra Colomina M, Pasquet M.   +4 more
europepmc   +1 more source

Serum proteomics analysis of lung transplant patients receiving different induction therapies. [PDF]

Front Immunol
Nasrollahi-Shirazi S, Unterwurzacher M, Berezhinskiy HO, Alemanno S, Hoetzenecker K, Aigner C, Jaksch P, Mohr T, Kratochwill K, Benazzo A.   +9 more
europepmc   +1 more source

First-in-Human Dose-Escalation Study of Fianlimab, an Antilymphocyte Activation Gene-3 Antibody, with Cemiplimab in Patients with Advanced Malignancies. [PDF]

Clin Cancer Res
Lakhani NJ, Papadopoulos KP, Johnson ML, Park H, Wang D, Yap TA, Dowlati A, Maki RG, Ulahannan S, Lynce F, Kelly K, Williamson S, Malhotra J, Chen S, Gonzalez Ortiz A, Jankovic V, Paccaly A, Masinde S, Mani J, Lowy I, Gullo G, Sims T, Kroog G.   +22 more
europepmc   +1 more source

Impact of graft-versus-host disease prophylaxis strategies on GvHD-free/relapse-free survival in young adults undergoing unrelated donor allogeneic haematopoietic cell transplantation: A propensity score-matched analysis. [PDF]

Br J Haematol
Desai N, Rodriguez SR, Al-Shaibani E, Moya TA, Novitzky-Basso I, Law AD.   +5 more
europepmc   +1 more source

Haploidentical transplantation with post-transplant cyclophosphamide is not inferior to 9/10-MUD transplantation with ATG in patients with myeloid malignancies. [PDF]

Bone Marrow Transplant
Gantner A, Labuhn S, Fürst D, Mannes S, Flossdorf S, Ayuk FA, Schroeder T, Stelljes M, Zeiser R, Dreger P, Eder M, Blau IW, Schetelig J, Brecht A, Burchert A, Edinger M, Wais V, Schrezenmeier H, Döhner H, Schmeller S, Fleischhauer K, Kröger N, Sala E, German Registry for Hematopoietic Stem Cell Transplantation and cell Therapy, DRST.   +24 more
europepmc   +1 more source

Low Absolute Lymphocyte Count Associated With Anti-Thymocyte Globulin Induction May Be a Predictor of Early Cytomegalovirus Infection in Pediatric Heart Transplantation. [PDF]

Pediatr Transplant
Chan A, Tan R, Tan S, Kuhn M, Shwaish N, Chinnock R, Tran H, Frandsen E.   +7 more
europepmc   +1 more source

Response to Letter to the Editor From Ville S. et al. About: "Eculizumab First" in the Management of Posttransplant Thrombotic Microangiopathy. [PDF]

Kidney Int Rep
Maritati F, La Manna G, Comai G.
europepmc   +1 more source